top of page

Pharmaceutical Products

Displayed on this page are pharmaceutical products in development by Innovative Potential.

Electramide

Electramide is a cyclophoshamide formulation in a CGP-friendly electrolyte solution.

Electramide is a specialty cyclophosphamide formulation for CGP and EAC drug development work including electrolysis assessments, in vitro bioassay screening, and in vivo testing.

Electramide is not a regulated medical product, and is for research purposes only.

Electramide
™ is not for human or veterinary use.

Electrophen

Electrophen is an acteaminophen  formulation in a CGP-friendly electrolyte solution.

Electrophen is a specialty acetaminophen formulation for CGP and EAC drug development work including electrolysis assessments, in vitro bioassay screening, and in vivo testing.

Electrophen is not a regulated medical product, and is for research purposes only.

Electrophen
™ is not for human or veterinary use.

ProLact

ProLact is a live-culture dairy product that contains a genetically modified organism (GMO) for lactose intolerant people.

ProLact™ is a GMO-probiotic that inhabits the gut microbiome for approximatley one week post consumption, and has been modified to constituitively express and secrete human lactase enzymes into the lumen of the small intestine. 

ProLact digests lactose using human lactase enzymes for people who are lactose intolerant.

ProLact is currently in development and not a regulated medical or food product, and is strictly for research purposes only, for now.

Not for human or veterinary use.

bottom of page